Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $980.00 Price Target at TD Cowen
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its target price lifted by equities research analysts at TD Cowen from $960.00 to $980.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. TD Cowen’s target price suggests a potential upside of […]
21 Oct 15:25 · The Markets Daily